Nanosponge: Versatile Drug Delivery System
-
Upload
biniyapatel -
Category
Health & Medicine
-
view
896 -
download
0
description
Transcript of Nanosponge: Versatile Drug Delivery System
1
Presented By
Patel Bindiya Ramesh
M.Pharm – (I semister)
(Pharmaceutics)
Under the guidance of
Dr. K. H. Ramteke
(M.Pharm, Ph.D.)
Dept. of Pharmaceutics
PE Society’sModern college of pharmacy (for ladies), Moshi,
Pune.
NANOSPONGEA BOON TO THE TARGETED DRUG DELIVERY SYSTEM
2
Aim & objective
What is nano sponge ?
Introduction
Advantages
Disadvantages
Factors influencing the formation of nanosponges
Method of preparation
Evaluation of nanosponges
Literature survey
Application
Conclusion
Referencea
Contents...
3
AIM : To review and study nanosponge as a novel & targeted drug delivery system.
To discuss nanosponges with their... Advantages & disadvantages,Factors influencing there formation, Method of preparation, Characterization, and Applications.
OBJECTIVE
4
Nanosponges are tiny sponges with a size of about a virus
(250nm – 1μm), which consist of cavities that can be filled with
a wide variety of drugs.
The sponge acts as a three-dimensional network or scaffold, which
consist of the backbone known as long-length polyester.
It is mixed in solution with cross-linkers to form the polymer.
What Is Nano Sponge ???
5
Targeting the drug delivery has long been a problem for medical
researchers how to get them to the right place in the body and how
to control the release of the drug to prevent overdose.
The development of new and complex molecules called
Nanosponges has the potential to solve these problems.
Nanosponge is a novel and emerging technology which play a vital
role in targeting drug delivery in a controlled manner.
Nanosponges are a new class of materials and made of microscopic
particles with few nanometres wide cavities in which a large variety
of substances can be encapsulated.
Introduction
6
A wide variety of drugs can be loaded into nanosponge for targeting drug
delivery.
These particles are capable of carrying both lipophilic and hydrophilic
substances and of improving the solubility of poorly water soluble
molecule.
Nanosponges are tiny mesh like structures is about the size of a virus
with a backbone of naturally degradable polyester.
They cross link segments of the polyester to form
a spherical shape that has many pockets / cavities where
drug can be stored.
Cont…
7
The nanoscale materials are small enough to be effective in attaching to or passing
through cell membranes.
The polyester is biodegradable, so it breaks down gradually in the body & releases
its drug payload in a predictable fashion.
These tiny sponges can circulate around the body until they encounter the specific
target site and stick on the surface and begin to release the drug .
As compared to other nanoparticles, nanosponges are porous, non toxic and
stable at high temperatures up to 300oC.
Cont …
8
The nanosponges are solid in nature and can be formulated as oral,
parenteral, topical or inhalational dosage forms.
For oral administration, these may be dispersed in a matrix of excipients,
diluents, lubricants which is suitable for the preparation of tablets or
capsules.
For parenteral administration, these can be simply mixed with sterile
water, saline or other aqueous solutions.
For topical administration, they can be
effectively incorporated into topical
hydro gel.
Cont…
9
Targeted site specific drug delivery.
Can be used to mask unpleasant flavours, odour and to convert liquid
substances to solids.
Less harmful side effects (since smaller quantities of the drug have
contact with healthy tissue).
Nanosponge particles are soluble in water, so the hydrophobic drugs can
be encapsulated within the nanosponge, after mixing with a chemical
called an adjuvant reagent.
Particles can be made smaller or larger by varying the proportion of
cross-linker to polymer.
Advantages of Nanosponges
10
Biodegradable.
Nanosponge formulations are stable over range of ph 1 to 11.
Nanosponge formulations are stable at the temperature up to 130˚c
These formulations are compatible with most vehicles and ingredients.
These are self sterilizing as their average pore size is 0.25μm where
bacteria cannot penetrate.
These formulations are free flowing and can be cost effective
Improved stability, increased elegance and enhanced formulation flexibility.
11
The main disadvantage of these nanosponges is their ability to include
only small molecules.
Dose dumping may take place.
May retard the release.
Materials Used For Preparation Of Nanosponges
DISADVANTAGE
Polymers : Hyper cross linked polystyrenes, ethyl cellulose, 2- hydroxy proply β – cyclodextrins, poly valerolactone, Eudragit RS 100, acrylic polymers
Cross linkers : Dichloromethane, diphenyl carbonate, acrylamido, glutarldehyde, Carboxylic acid dianhydride ,
12
Type of polymer : Type of polymer used can influence the formation as well
as the performance of Nanosponges. For complexation, the cavity size of
nanosponge should be suitable to accommodate a drug molecule of particular
size.
Type of drugs : Molecules to be complexed with nanosponges should have
certain characteristics mentioned below
1. Molecular weight between 100 – 400 Da .
2. Drug molecule consists of less than five condensed rings .
3. Solubility in water is less than 10mg/mL .
4. Melting point of the substance is below 250°C.
Factors influencing the formation of nanosponges
13
Temperature : Increasing in the temperature decreases the stability of
the drug/nanosponge complex, may be due to a result of possible
reduction of drug/nanosponge interaction forces.
Method of preparation : The method of loading the drug into the
nanosponge can affect Drug/Nanosponge complexation.
Degree of substitution : The complexation ability of the nanosponge
may be greatly affected by type, number and position of the substituent
on the parent molecule.
14
1 • Polymer is mixed with a suitable solvent like polar aprotic solvent.
2• This mixture is added to excess quantity of
the cross-linker preferably in cross-linker/polymer molar ratio of 1:4.
3• Action is carried out at temperature
ranging from 10°C to the reflux temperature of the solvent, for time ranging from 1 to 48 hr
4• After completion of the reaction, the solution
is cooled at room temperature and the product is added to large excess of distilled water.
5 • The recovery of the product is done by filtration under vacuum.
METHOD OF PREPARATION
1. Solvent method
15
Nanosponges are obtained by reacting cyclodextrin with a cross-
linker such as di isocianates, diaryl carbonates, dimethyl
carbonate, diphenyl carbonate, and carbonyl diimidazoles.
The average diameter of a Nanosponge is below 1 µm but
fractions below 500 nm can be selected.
2. Hyper Cross- Linked β- Cyclodextrins
CYCLODEXTR
IN
CROSS-LINKER
IN SOLVENT
NANOSPONGE
16
• In this method, nanosponges can be obtained by reacting polymers
with cross-linkers in the absence of solvent and under sonication.
• The nanosponges obtained by this method will be spherical and
uniform in size.
4. Ultrasound-Assisted synthesis
17
Organic internal phase containing drug & polymer in solvent is added to
External phase containing emulsifying agent
Than mixture is stirred at 1000-2000 rpm for 3 hrs at RT
Formed nanosponge were filtered, washed & dried at RT
3. Emulsion Solvent Diffusion Method
18
Suspend the nanosponges in
water and sonicate to avoid the
presence of aggregates
then centrifuge the suspension to
obtain the colloidal fraction
Prepare aqueous
suspension of
Nanosponge and
disperse the excess amount of the drug
and maintain
the suspension
under constant
stirring at specific time for
complexation
Nanosponges
Loading Of Drug Into Nanosponges
After complexation, separate the uncomplexed
(undissolved) drug by centrifugation
Then obtain the solid crystals of nanosponges
by
19
Author Aim Method used Result
CH.N.V. Raja*, G.
Kiran kumar,
Kotapati anusha
Fabrication And Evaluation Of
Ciprofloxacin Loaded Nanosponges For Sustained Release
Solvent method
Formulated NS loaded with Ciprofloxacin antibiotic resulted in sustained release. Among all batches (F5) is considered as the best entrapped (90.80%) NS with greater % drug release (99.4%).
Roberta Cavalli, Ansari Khalid Akhter, Agnese Bisazza
Nano sponge formulation as oxygen
delivery system
Hyper Cross- Linked β-
Cyclodextrins
NS were able to encapsulate, store & release oxygen for prolonged time. US enhanced release & permeation of oxygen. NS is suitable carrier & act as oxygen reservior.
Literature surveys
20
Author Aim Method used Result
E. K. PATEL* and RJ. OSWAL
Nanosponge for delivery of calcium in hyperphosphatemia
Hyper Cross- Linked β- Cyclodextrins
SEM – roughly spherical shape, porous in nature & mean particle size - 400nm. zeta potential is high enough. encapsulation efficiencies – 81 – 95 %
Renuka Sharma , Roderick B. Walker and Kamla Pathak *
Evaluation of the Kinetics and Mechanism of Drug Release from Econazole nitrate Nanosponge Loaded Carbapol Hydrogel
Emulsion solvent method
A sustain release topical DDS of econazole nitrate developed as o NS hydro gel offered solubilising matrix for poorly soluble drug. Served as a local depot for sustain drug release.
21
Particle Size Determination : Particle size can be determined by laser light diffractometry or Zeta seizer.
Loading Efficiency : The loading efficiency (%) of Nanosponge can be determined by,
Actual drug content
Loading Efficiency = ---------------------------------- X 100
Theoretical drug content
EVALUATION OF NANOSPONGES
22
UV spectroscopy is used to carry out the saturated solution interaction
study.
Increasing concentrations of nanosponge solutions (1– 80 ppm) are added
to fixed concentrations of the drug.
The samples are kept overnight for interaction and finally filtered solutions
are scanned for λmax and absorbance is measured.
Drug loading is interpreted by taking scans of the formulation in the UV
range and analyzing the shift of the absorbance maxima in the spectra
compared to pure drug.
• Saturation state interaction
23
Bulk volume – True volume
% Porosity (E) = ------------------------------------------ x 100
Bulk volume
Zeta potential :
Zeta potential of any system under investigation is a measure of the surface charge.
SEM and TEM :
These tools are employed to evaluate the particle shape and size and to get morphological information related to the drug delivery system
Fourier transform-infrared spectroscopy (FTIR) :
It serves as a major tool to determine the presence of functional groups.
Porosity : Percent porosity is given by equation
24
Diffraction peaks for a mixture of compounds are useful in
determining chemical decomposition and complex formation.
Complex formation of the drug with nanosponges alters the
diffraction patterns and also changes the crystalline nature of
the drug.
Thermo gravimetric analysis (TGA)
These studies are carried out to understand the melting point, thermo
stability and crystalline behaviour of the particle.
Powder X-ray diffraction (P-XRD)
25
Marking of the cylinder at a specified
time point
Percentage of swelling = -----------------------------------------------------x 100
Initial marking before soaking
Mass of the hydro gel after 72 hrs
Percentage of water uptake = -----------------------------------------------x 100
Initial Mass of dry polymer
Swelling and water uptake
26
• In vitro release kinetics experiments are performed using a multi-
compartment rotating cell; an aqueous dispersion of nanosponges (1
mL) containing the drug is placed in the donor compartment, while the
receptor compartment, separated by a hydrophilic dialysis membrane,
is filled with phosphate buffer at pH 7.4 or pH 1.2.
• Each experiment is carried out for 24 h.
• At fixed times, the receptor buffer is completely withdrawn and replaced
with fresh buffer. The amount of drug in the medium is determined by a
suitable analytical method and drug release is calculated to determine
the release pattern.
Drug release kineticsIn vitro diffusion model
27
Spontaneous.
Carcinogen-induced.
Gems (genetically engineered mouse models).
–transgenic
–knockout
–regulatable transgenic
CELL LINES
HT-29 cell line
MCF-7 cell line
In vivo models
28
Spontaneous model
Some strains of laboratory animals are susceptible to spontaneously developing certain types of tumor.
Advantagesmay mimic some types of human diseasescan use to study early disease.can use for prevention.includes elements of progression
DisadvantagesVariability of disease progression.Large animal numbers needed.Long time to develop disease.penetrance (not all animals get disease).
29
Marketed preparation
Paclitaxel, camptothecin, tamoxifen, econazole nitrate, peroxidase
Drug Administration route
Trade name Market
Dexamethasone Dermal Glymesason Japan
Iodine Topical Mena-gargle Japan
Alprostadil I.V Prostavastin Europe, Japan, USA
Piroxicam Oral Brexin Europe
Temoxifen Oral - -
Other examples patented drugs used in nanosponge preparation
30
Cancer.
Oxygen delivery systems.
As a carrier for biocatalysts and in the delivery
and release of enzymes, proteins, vaccines and antibodies.
Harvesting of rare Cancer Marker from Blood.
Solubility enhancement.
Topical drug delivery system.
Antiviral application.
More effectiveness than direct injection.
APPLICATION
31
The nanosponges have the ability to include either lipophilic or
hydrophilic drugs and release them in a controlled and predictable
manner at the target site. By controlling the ratio of polymer to the cross-
linker the particle size and release rate can be modulated. Nanosponges
enable the insoluble drugs and protect the active moieties from
physicochemical degradation and controlled release. Because of their
small size and spherical shape nanosponges can be developed as different
dosage forms like parenteral, aerosol, topical, tablets and capsules.
Thus, the nanosponge drug delivery system is a boon in the area of
targeted and site specific drug delivery system.
CONCLUSION
32
REFERENCES
G. Yadav., H. Panchory., Nanosponge: A Boon To The Targeted Drug Delivery System, Journal Of Drug Delivery And Therapeutics; 2013, Volume 3(4), Pg. No. 151-155.
F. Trotta., R. Cavalli., Characterization And Applications Of New Hyper Cross - Linked Cyclodextrin, Composite Interfaces, 2009, Volume 16, Pg. No. 39-48.
G. Jilsha., Vidya Viswanad., Nanosponges: A Novel Approach Of Drug Delivery System; Int. J. Pharm. Sci. Rev. 2013 Res Volume 19 (2), Pg. No.119-123.
C. U. Shah, Cyclodextrin Based Nanosponges For Pharmaceutical Use: A Review; Acta Pharm. 2013, Volume 63, Pg. No. 335-358.
S.P. Vyas, R.K. Khar. Targeted And Controlled Drug Delivery- Novel Carrier Systems. Molecular Basis Of Targeted Drug Delivery. Cbs Publishers And Distributors. New Delhi. 2008: Pg. No. 38- 40.
S. Subramanian, A. Singireddy., Nanosponges: A Novel Class Of Drug Delivery System; J Pharm Pharmaceut Sci: 2012, Volume 15(1), Pg. No. 103-111.
33